AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04928183 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Phenylephrine Hydrochloride
Description: Bolus Phenylephrine injection for observe α1-mediated vasoconstriction during mild exercise
Study NCT06364280 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BVM
Description: Bag-Valve-Mask Ventilation
Study NCT06364280 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SGA
Description: Supraglottic Airway
Study NCT06364280 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ETI
Description: Endotracheal Intubation
Study NCT06129227 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dual-task training
Description: This group will receive 30 min of dual-task exercise training and 30 min of stretching exercises in each session. The dual-task component involves walking activities performed in conjunction with cognitive activities. For the stretching exercise component, no cognitive load will be added.
Study NCT06129227 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Single-task training
Description: This group will undergo 30 min of single-task mobility training and another 30 min of single-task cognitive activities. The cognitive and mobility exercises will be the same as those in the dual-task group, but they will be performed separately. No extra cognitive load will be imposed during the mobility exercises. No additional motor demand will be imposed during the cognitive exercises, as the participants will be sitting.
Study NCT06129227 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: This group will undergo 30 min of stretching exercises (same as the dual-task group) and another 30 min of upper limb strengthening exercises performed primarily in the sitting or lying position. No cognitive load will be added.
Study NCT04885296 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TRP-200
Description: JJVC Investigational Contact Lens
Study NCT04885296 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: JJVC Marketed Contact Lens
Description: ACUVUE Oasys 1-Day
Study NCT04751669 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin and trace elements
Description: Dietary supplement oral route, once a day, during 14 days
Study NCT04751669 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Dietary supplement (placebo) oral route, once a day, during 14 days
Study NCT05397028 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Meal replacement system
Description: Participants will replace meals with a meal replacement system to assess the efficacy of weight loss leading to remission of diabetes (optimal A1C levels).
Study NCT05397028 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle Intervention
Description: Participants will sign up with a virtual health program which they will interact with.
Study NCT06277973 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Description: The intervention is based on EMDR therapy for PTSD treatment. Participants will answer demographic questions, choose a primary distress source and watch a therapist-guided video (male or female, based on participant choice) that will instruct them through the 'Butterfly Hug' method (tapping alternately on both sides of the body) while hearing positive statements from the therapists on the chosen distress source. Before and after each video participants will rate their distress level on a scale between 0 and 10 and they can view up to 8 videos per session. The system will monitor distress levels, and if it detects a sustained deterioration, it will end the intervention. At the end of the intervention, participants will be given information about possible reactions to it and how to deal with them, they will be encouraged to use the technique whenever necessary, and they will be informed of relevant support lines that they can contact if needed.
Study NCT06277973 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Description: The intervention is based on EMDR therapy for PTSD treatment. Participants will answer demographic questions, choose a primary distress source and watch a therapist-guided video (male or female, based on participant choice) that will instruct them through the 'Butterfly Hug' method (tapping alternately on both sides of the body) while hearing positive statements from the therapists on the chosen distress source. Before and after each video participants will rate their distress level on a scale between 0 and 10 and they can view up to 8 videos per session. The system will monitor distress levels, and if it detects a sustained deterioration, it will end the intervention. At the end of the intervention, participants will be given information about possible reactions to it and how to deal with them, they will be encouraged to use the technique whenever necessary, and they will be informed of relevant support lines that they can contact if needed.
Study NCT04995094 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Imprime PGG
Description: Imprime PGG is a soluble, β-1,3/1,6 glucan isolated from the cell wall of a proprietary Saccharomyces cerevisiae yeast strain. Imprime PGG acts as a Pathogen-Associated Molecular Pattern (PAMP). Imprime will be administered at a dose of 4 mg/kg IV over a 2-hour infusion time on Days 1, 8 and 15 of each 3-week treatment cycle.
Study NCT04995094 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab is a humanized monoclonal antibody against the programmed death receptor-1 (PD-1) protein. Pembrolizumab will be administered at 200 mg IV Q3W for 9 weeks.
Study NCT04995094 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab
Description: Pembrolizumab is a humanized monoclonal antibody against the programmed death receptor-1 (PD-1) protein. Pembrolizumab will be administered at 200 mg IV Q3W for 9 weeks.
Study NCT05631002 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Chemical shift encoding-based water-fat MRI
Description: Chemical shift encoding-based water-fat magnetic resonance imaging (MRI): a non-invasive method
Study NCT04939506 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COVID-19 Vaccine Education at the Point of COVID-19 Testing
Description: A rapid vaccination education model to be delivered at the point of COVID-19 testing by pharmacy students, pharmacy technicians, nurse's aides and other health care personnel. The intervention will include: 1) 15 minute vaccine counseling, 2) print material 3) referral to a dedicated vaccine website with feedback forums and 4) opportunity to sign-up for one-on-one vaccine counseling with a clinical pharmacist
Study NCT05957705 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Maxilar Sinus augmentation
Description: The patients will be submitted to bilateral sinus augmentation using two different techniques to provide enough bone tissue for dental implants placement.
Study NCT05957705 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Dental implant placement using guided surgery
Description: After 4 months of sinus augmentation, patients will be prepared to receive dental implants for oral rehabilitation. Performed by guided surgery the implants will be placed at the best location for the rehabilitation and at the place were the sinus lighting were performed.
Study NCT06312696 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SMT
Description: SMT will be provided by a licensed chiropractor with at least 5 years' experience.~Treatment will last 15 to 20 minutes each and include a brief history and examination of the cervical spine. SMT will consist of low velocity, variable amplitude spinal mobilization to the cervical spine - Maitland grades 3 or 4. Spinal segments will be determined by the chiropractor using manual palpation and the patients' response to care. Drop-table or instrument-assisted SMT will not be allowed.
Study NCT06312696 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Light Massage
Description: Light Massage will be provided as a pseudo-sham intervention to control for time, attention, and touch by a licensed chiropractor with at least 5 years' experience to control for touch and is intended to be delivered gentler and shorter than recommended for therapeutic massage.
Study NCT05750199 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Immunotherapy Special Training Course (ISTC)
Description: 16 weeks and includes 8 hours of digital media training and 2 days of workshop training.
Study NCT05750199 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Advanced Oncology Nurse Training Course (AONTC)
Description: 4 weeks and includes 8 days of Advanced Oncology Nurse Training Course
Study NCT05363254 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Marlboro Gold Box
Description: A combustible cigarette
Study NCT05363254 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Newport Box
Description: A combustible cigarette
Study NCT05363254 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-combusted cigarette variant 42001401
Description: A menthol flavor variant of a non-combusted cigarette (42001401)
Study NCT05363254 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-combusted cigarette variant 42001399
Description: A menthol flavor variant of a non-combusted cigarette (42001399)
Study NCT05363254 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-combusted cigarette variant 40007386
Description: A menthol flavor variant of a non-combusted cigarette (40007386)
Study NCT05363254 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-combusted cigarette variant 42001402
Description: A non-menthol flavor variant of a non-combusted cigarette (42001402)
Study NCT04712240 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Respiration rate monitor
Description: A portable continuously monitoring respiration rate monitor will be fitted to each participant. The respiration rate monitor is housed within a comfortable chest strap that be secured to the participant for the duration of the surgical procedure
Study NCT04939688 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Conventional dose AND ultra low-dose CT scanning in the search for cranial lesions
Description: As well as undergoing the usual, conventional radiation dose CT scan, these patients will also undergo ultra low-dose CT scanning in the search for cranial lesions.
Study NCT06286709 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Faecal Microbiota Transplant
Description: FMT is 50mL aliquots of filtered suspension of stool (0.6g/mL). FMT for administration via colonoscopy will be made up of 150g stool in 250mL (5 aliquots). FMT for administration via enema will be made up of 30g stool in 50mL (1 aliquot) made up to 100mL by the addition of 50mL normal saline
Study NCT06286709 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: FMT Placebo
Description: FMT Placebo is 50mL aliquots containing 0.9% w/v saline and glycerol in a ratio of 9 parts saline: 1 part glycerol v/v. FMT Placebo for administration via colonoscopy will be made up of 250mL (5 aliquots). FMT Placebo for administration via enema will be made up of 50mL (1 aliquot) made up to 100mL by the addition of 50mL normal saline
Study NCT05365685 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low energy turnover
Description: Low Energy Turnover. The adolescents with ingest low energy intake at lunch and breakfast and will not perform physical exercise during the day. The will will receive an ad libitum meal at dinner time. Their food reward will be assessed before dinner. Their appetite feelings will be assessed at regular intervals.~Moderate Energy Turnover. The adolescents with ingest moderate energy intake at lunch and breakfast and will perform one 45 minutes physical exercise during the day. The will will receive an ad libitum meal at dinner time. Their food reward will be assessed before dinner. Their appetite feelings will be assessed at regular intervals.~High Energy Turnover. The adolescents with ingest high energy intake at lunch and breakfast and will perform two 45-minute physical exercises during the day. The will will receive an ad libitum meal at dinner time. Their food reward will be assessed before dinner. Their appetite feelings will be assessed at regular intervals.
Study NCT06505733 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: postnatal attendant training
Description: Intervention Group: Training and counselling will be provided to the puerperant and companions before discharge in a quiet and stimulus-free environment using the Companion Training Guide. Research data will be collected three times: pre-test data, after the training and on the tenth day.
Study NCT05683353 — intervention group
Intervention type: OTHER
Intervention: None intervention
Description: None intervention.
Study NCT04966910 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stay Connected
Description: Stay Connected is a menu-driven set of strategies to combat loneliness, anxiety and depression in older adults based on behavioral activation principles.
Study NCT04966910 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: Regular check-ins, resource/referral provision
Study NCT04542603 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [11C]PiB and 18F-labeled DPA-714 PET scan
Description: One PET with \[11C\]PiB and One PET with \[18F\]DPA-714 before chemotherapy treatment begins. One more PET with \[18F\]DPA-714 after completion of 3-6 cycles of chemotherapy.
Study NCT04594278 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Intervention
Description: A remotely delivered closed group mindfulness-based intervention using Microsoft Teams Meeting will be performed, consisting of 12-16 participants (Maximum 10 groups) and one professional with a background in mindfulness coaching . Three professionals will be coaching 2-3 groups each. The curriculum entails weekly sessions (1 hour) over a 4-week period.
Study NCT06243523 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: The stress management psychoeducation program based on Neuman's Systems Model
Description: The stress management psychoeducation program will be implemented in six sessions with individual interviews lasting approximately 45-60 minutes, three times a week for the spouses of patients in intensive care. The first session includes the meeting and introduction of the psychoeducation program. The second session includes the adaptation process to the intensive care unit. The third, fourth and fifth sessions include methods of coping with stress. The sixth session includes evaluation and termination of the psychoeducational program. Quantitative data of the research will be collected with the pre-action and post-action Psychological Distress Scale and the Stress Coping Styles Scale. Qualitative data of the research will be collected through semi-structured individual in-depth interviews conducted after the action.
Study NCT05778422 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Suprascapular nerve block with bipuvacaine
Description: Suprascapular nerve block with Bipuvacaine: a 50mm 22G needle (Stimuplex, BBraun) was introduced up to the suprascapular fossa, guided by ultrasound, and the location was confirmed by motor stimulation with contraction of the supraspinatus and infraspinatus muscles. Next, 5 ml of 0.25% bupivacaine with adrenaline was injected.
Study NCT05778422 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pulsed radiofrequency
Description: After confirming the location, the needle mandrel was removed and the radiofrequency cannula was introduced through the needle, 2ml of 1% lidocaine without epinephrine was injected, followed by application of pulsed radiofrequency for 180sec at 42°C by radiofrequency (radiofrequency generator system BMS-50N, Bramsys).
Study NCT04589091 — intervention group
Intervention type: OTHER
Intervention: Refractive surgery
Description: Refractive surgery for correction of error of refraction
Study NCT05911594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Solifenacin group
Description: Patients in this group will receive medical treatment (Solifenacin 5 mg once or twice daily) without any second line of treatment
Study NCT05342285 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Flow mediated dilation
Description: flow mediated dilation in brachial artery
Study NCT06149130 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab
Description: adebrelimab:1200mg intravenously, Q3W.
Study NCT06149130 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dalpiciclib
Description: dalpiciclib:150mg once a day for 3 weeks and stop for 1 week. Q4W.
Study NCT03598374 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Inositol + Folic acid
Description: Daily oral supplementation of for 6 months or until pregnancy conception:~Myo-Inositol: 1100 mg D-chiro-inositol: 27.6 mg Folic acid: 400 mcg
Study NCT03598374 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Folic acid
Description: Daily oral supplementation of for 6 months:~Folic acid: 400 mcg
Study NCT03598374 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Regular intercourses
Description: Couples are required to have regular intercourses with the aim to achieve a spontaneous conception.
Study NCT03598374 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Regular intercourses
Description: Couples are required to have regular intercourses with the aim to achieve a spontaneous conception.
Study NCT05757245 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: GMCN-508A Drug Product
Description: Transplant of autologous hematopoietic stem and progenitor cells transduced with GMCN-508A lentiviral vector.
Study NCT05911594 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Percutaneous tibial nerve stimulation group
Description: Patients in this group will receive Percutaneous tibial nerve stimulation after failure of medical therapy
Study NCT05911594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intradetrusor BOTOX group
Description: Patients in this group will receive Intradetrusor BOTOX after failure of medical
Study NCT05551780 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SoundBite Crossing System
Description: Use of the SoundBite Crossing System to cross calcified chronic total occlusions
Study NCT05911594 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Intradetrusor BOTOX combined with Percutaneous tibial nerve stimulation group
Description: Patients in this group will receive Intradetrusor BOTOX combined with Percutaneous tibial nerve stimulation after failure of medical
Study NCT06068582 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Strenghtening the brain
Description: Lifestyle intervention containing physical exercise, lifestyle coaching, and cognitive training. The programme contains weekly 30 minutes 1-on-1 fitness and lifestyle coaching with two moments of exercise at home for 20 minutes. Online computerized cognitive training will be done for 60 minutes per week.
Study NCT06068582 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Strengthening the mind
Description: Work-focused intervention combining the capability approach and the participatory approach. Together with a work-coach who has been diagnosed with MS themselves, participants will assess important work values, discover challenges participants are facing, think of solutions for these challenges, develop a plan of action and implement these solutions.
Study NCT06259799 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smart Water Bottle
Description: Participants in the intervention group will receive a bottle which measures participant fluid consumption. The bottle will be set to recommend 2.5L for male participants and 2.0L for female participants, consistent with fluid intake recommendations from the European Food Safety Authority for each sex. Participants will be prompted by the bottle (bottle will light up) when they are behind on fluid intake recommendations. Participants will use a validated urine color chart, 9 point Likert scale for thirst, and measure nude body mass on their own each morning. Participants will be informed that higher values for nude body mass and thirst, and lower values for nude body mass each morning may indicate they are less hydrated day-to-day.
Study NCT05983562 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary Supplement: D-β-hydroxybutyric acid with R-1,3-butanediol
Description: Pre-intervention (baseline) and post-intervention measurements will be obtained before and after the 90-day period respectively.
Study NCT05983562 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Inert placebo
Description: Pre-intervention (baseline) and post-intervention measurements will be obtained before and after the 90-day period respectively
Study NCT05220683 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: digital marking system
Description: Verion or Callisto, digital marking system
Study NCT05357898 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SQZ-eAPC-HPV
Description: Enhanced antigen presenting cells (eAPC) cell therapy; therapeutic vaccine engineered from autologous peripheral blood mononuclear cells (PBMCs) by incorporating 5 mRNAs.
Study NCT05357898 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: programmed cell death 1 (PD-1) blocking antibody
Study NCT06406491 — intervention group
Intervention type: DEVICE
Intervention: active microprocessor-controlled knee
Description: Active microprocessor-controlled knees are motorized prosthesis, actively supporting the users while walking, getting up, and climbing stairs.